Prescription Levothyroxine Sodium Oral Solution Nationwide Recall Due to Subpotency
IBSA Pharma has recalled TIROSINT levothyroxine sodium oral solution nationwide due to subpotency. Affected lots 220418 and 220560 may contain insufficient active ingredient for proper thyroid hormone replacement therapy.
- Product
- TIROSINT — TIROSINT (LEVOTHYROXINE SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide